Carta científico-clínica
Vasculopatía livedoide tratada con rivaroxabán. Potenciales usos de los nuevos anticoagulantes orales para el dermatólogo
Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists
Leído
23375
Vecesse ha leído el artículo
3295
Total PDF
20080
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 235 | 35 | 270 |
| 2025 9 | 173 | 28 | 201 |
| 2025 8 | 194 | 38 | 232 |
| 2025 7 | 329 | 24 | 353 |
| 2025 6 | 298 | 24 | 322 |
| 2025 5 | 602 | 38 | 640 |
| 2025 4 | 609 | 39 | 648 |
| 2025 3 | 767 | 32 | 799 |
| 2025 2 | 574 | 47 | 621 |
| 2025 1 | 487 | 34 | 521 |
| 2024 12 | 600 | 49 | 649 |
| 2024 11 | 404 | 57 | 461 |
| 2024 10 | 373 | 63 | 436 |
| 2024 9 | 315 | 28 | 343 |
| 2024 8 | 391 | 52 | 443 |
| 2024 7 | 394 | 48 | 442 |
| 2024 6 | 462 | 40 | 502 |
| 2024 5 | 337 | 37 | 374 |
| 2024 4 | 335 | 53 | 388 |
| 2024 3 | 434 | 37 | 471 |
| 2024 2 | 445 | 32 | 477 |
| 2024 1 | 408 | 27 | 435 |
| 2023 12 | 406 | 26 | 432 |
| 2023 11 | 502 | 42 | 544 |
| 2023 10 | 430 | 42 | 472 |
| 2023 9 | 485 | 54 | 539 |
| 2023 8 | 298 | 31 | 329 |
| 2023 7 | 375 | 60 | 435 |
| 2023 6 | 334 | 37 | 371 |
| 2023 5 | 238 | 38 | 276 |
| 2023 4 | 307 | 38 | 345 |
| 2023 3 | 306 | 51 | 357 |
| 2023 2 | 283 | 60 | 343 |
| 2022 1 | 453 | 41 | 494 |
| 2022 12 | 226 | 56 | 282 |
| 2022 11 | 271 | 58 | 329 |
| 2022 10 | 300 | 69 | 369 |
| 2022 9 | 278 | 59 | 337 |
| 2022 8 | 242 | 63 | 305 |
| 2022 7 | 256 | 71 | 327 |
| 2022 6 | 284 | 54 | 338 |
| 2022 5 | 256 | 74 | 330 |
| 2022 4 | 281 | 46 | 327 |
| 2022 3 | 293 | 139 | 432 |
| 2022 2 | 278 | 48 | 326 |
| 2021 1 | 337 | 80 | 417 |
| 2021 12 | 202 | 47 | 249 |
| 2021 11 | 243 | 65 | 308 |
| 2021 10 | 215 | 75 | 290 |
| 2021 9 | 168 | 56 | 224 |
| 2021 8 | 198 | 62 | 260 |
| 2021 7 | 131 | 41 | 172 |
| 2021 6 | 132 | 50 | 182 |
| 2021 5 | 131 | 52 | 183 |
| 2021 4 | 283 | 149 | 432 |
| 2021 3 | 224 | 51 | 275 |
| 2021 2 | 153 | 34 | 187 |
| 2020 1 | 98 | 25 | 123 |
| 2020 12 | 95 | 26 | 121 |
| 2020 11 | 132 | 27 | 159 |
| 2020 10 | 111 | 24 | 135 |
| 2020 9 | 101 | 39 | 140 |
| 2020 8 | 88 | 30 | 118 |
| 2020 7 | 99 | 38 | 137 |
| 2020 6 | 73 | 35 | 108 |
| 2020 5 | 77 | 26 | 103 |
| 2020 4 | 33 | 25 | 58 |
| 2020 3 | 48 | 19 | 67 |
| 2020 2 | 7 | 0 | 7 |
| 2020 1 | 5 | 0 | 5 |
| 2019 12 | 2 | 0 | 2 |
| 2019 11 | 4 | 0 | 4 |
| 2019 10 | 3 | 0 | 3 |
| 2019 9 | 4 | 0 | 4 |
| 2019 8 | 18 | 2 | 20 |
| 2019 7 | 14 | 6 | 20 |
| 2019 6 | 8 | 4 | 12 |
| 2019 5 | 9 | 3 | 12 |
| 2019 4 | 3 | 0 | 3 |
| 2019 3 | 1 | 1 | 2 |
| 2019 2 | 4 | 4 | 8 |
| 2019 1 | 4 | 3 | 7 |
| 2018 12 | 7 | 9 | 16 |
| 2018 11 | 8 | 6 | 14 |
| 2018 10 | 8 | 12 | 20 |
| 2018 9 | 1 | 0 | 1 |
| 2018 8 | 0 | 2 | 2 |
| 2018 6 | 6 | 1 | 7 |
| 2018 5 | 8 | 5 | 13 |
| 2018 4 | 36 | 27 | 63 |
| 2018 3 | 0 | 1 | 1 |
| 2018 1 | 0 | 5 | 5 |
| 2017 12 | 0 | 1 | 1 |
| 2017 11 | 0 | 4 | 4 |
| 2017 10 | 0 | 4 | 4 |
Mostrar todo
